The anticonidial activity of human monocytes deactivated by cytokines interleukin (lL)-4 and IL-10 and the hormone dexamethasone was studied and compared with antilisterial activity. Dexamethasone had the largest effect on the anticonidial activity and suppressed germination-inhibiting activity and elimination of ingested spores by macrophages more than the cytokines did. Maximally active concentrations of IL-10 had a similar but significantly smaller deactivating effect. IL-4, in contrast to IL-lO and dexamethasone, did not reduce anticonidial activity. However, IL-4 and IL-10 were equally potent in deactivating human macrophages against Listeria monocytogenes, whereas dexamethasone was significantly less potent in the Listeria model. These observations indicate that all three mediators lessen antimicrobial activity but that this effect depends on the test organism studied and is apparently mediated through regulation of different antimicrobial systems operating against a particular microorganism.
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Macrophages take a central role in natural resistance to conidia from Aspergillus species as well as Listeria monocytogenes in experimental and presumably also natural infection [1] [2] [3] . Human macrophages derived from blood monocytes are highly efficient in controlling both organisms, even in the absence of activation by cytokines, but they lose their capability to kill these microorganisms and to suppress their growth when exposed to pharmacologic concentrations of glucocorticoids [4] . Previous studies from our laboratory have shown that dexamethasone apparently interferes with nonoxidative killing systems of resting human macrophages, but the nature of these systems is unknown [4, 5] .
In the present study, we compared the effects of dexamethasone as well as interleukin (IL )-4 and IL-l 0, two other mediators of deactivation [6] , on the activity of human macrophages against L. monocytogenes and Aspergillus fumigatus.
Materials and Methods
Organisms. A strain of A. fumigatus from previous studies was used for all experiments, and single-spore suspensions were prepared as described [4] . For challenge, conidia were directly diluted in complete medium at a concentration of 2 X 10 5 spores/ mL. L. monocytogenes EGD was cultured and prepared as described [5] .
Cell cultures. Human monocyte cultures were obtained after gradient separation of mononuclear cells from heparinized blood from healthy volunteers as described [5, 7] . Monolayers of monocytes on 12-mm glass coverslips, freed from contaminating lymphocytes by washing away nonadherent cells, were placed in 35-mm tissue culture dishes (Falcon Plastics, Oxnard, CA) containing four coverslips each with 30,000-40,000 monocytes with a purity of >98% in 2 mL of complete medium [7] . Culture conditions were 37°C, 98% humidity, and 5% CO 2 . Complete medium was Medium 199 (GISCO Europe, Basel, Switzerland) supplemented with 25% pooled normal human serum. A single lot of pooled serum stored in aliquots at -70°C was used throughout the experiments.
Cytokine supplements. Human recombinant IL-4 was from Schering-Plough (Kenilworth, NJ) and was used in a final concentration of 1 ng/mL. Human recombinant IL-IO was from PeproTech (Rocky Hill, NJ) and used in a final concentration of 5 ng/ mL. Human recombinant tumor necrosis factor-a (TNF-a) was from Knoll (Ludwigshafen, Germany). The three cytokines were dissolved in PBS and then diluted in medium. Dexamethasone (Sigma, St. Louis) was dissolved at a concentration of 2.5 X 10-2 M in ethanol before dilution in medium to a final concentration of 2.5 X 10-7 M. All cytokines and dexamethasone have been shown in dose-finding studies to be maximally active at these concentrations [7] . Appropriate solvent controls were added to control cultures at the same time as the supplements.
Tests for antimicrobial activity. Anticonidial activity was assessed as described [4] . In brief, germination of phagocytized spores was enumerated 18 h after challenge of monolayers that had been pretreated for 36 h with the indicated cytokines on Giemsa-stained coverslips [4] . Germination rates of control spores incubated in cell-free complete medium was always >99%. The analysis of germination rates was based on 4x 200 spores from quadruplicate wells per condition and experiment.
Disappearance of spores by digestion was quantitated by enumerating the decrease in spores on the basis of phagocytic index immediately after phagocytosis and removal of noningested spores by washing and incubation for 18 h as described [8] . This analysis was based on 4x 400 macrophages from quadruplicate wells per condition and experiment and time point.
Antilisterial activity was assessed as described [4, 5] by following the percentage of mononuclear phagocytes harboring bacteria during an incubation period of 7 h after phagocytosis and washing off non -cell-associated bacteria. After non -cell-associated bacteria or conidia were washed off, dexamethasone and cytokines were again added to cultures at the indicated concentrations. Of note, IL-I, IL-4, and dexamethasone did not affect the phagocytic index, as shown previously [7] .
Measurement ofH 202 secretion and NO production. HzO z secretion in response to phorbol myristate acetate stimulation was measured by chemiluminescence as described [5] . NO was measured as nitrite accumulation during 24 h with the Griess reagent as described [9] .
Statistical analysis. Mean and SE (combined data from several experiments) or SD (single experiments) are given. Bonferroni's correction for multiple comparisons and Dunnett's test for comparison of multiple samples with one control were done using a computer-based program (lnstat; Graphpad, San Diego). 
IL-4 Results
Deactivation of anticonidial activity. Dexamethasone was most potent in deactivating anticonidial activity of human monocytes, followed by IL-IO. IL-4 had no effect on anticonidial activity (figure I). Assessment of the anticonidial activity by quantification of germination rates of spores 18 h after phagocytosis or digestion of spores during phagocytosis for 18 h can be done in parallel. However, anticonidial activity can probably be even more accurately determined by quantification of the percentage of spores germinating in relation to the spores originally ingested by macrophages (i.e., percentage of spores germinating at 18 h of incubation among number of spores remaining at 18 h plus number of spores digested during 18 h of incubation). In any event, all three methods of assessment indicated that dexamethasone was more potent than IL-I0 in deactivating macrophages and that IL-4 had no effect on anticonidial activity.
Comparison of deactivation of antilisterial and anticonidial activity and relation to NO production and H 202 secretion. In contrast to results from experiments with A. fumigatus, antilisterial activity was most strongly reduced by IL-4 and IL-10; dexamethasone had a much lower activity than the tested cytokines (table 1, P < .001). Furthermore TNF-a, which did not restore anticonidial activity of macrophages deactivated with any of the three tested mediators of deactivation, significantly increased antilisterial activity in macrophages deactivated with IL-I0 and IL-4 (table 1). During the experiments, no detectable amount of nitrite accumulated in supernatants of phagocytes before challenge with the microorganisms or after. Only deactivation by IL-l 0 was associated with a significantly decreased secretion of H z 0 2 during the respiratory burst (table 1). 
Discussion
In these studies, mediators of macrophage deactivation (IL-10, IL-4, dexamethasone) affected different phagocytic effector systems differently, and deactivation characterized by assessment of antimicrobial activity depended on the test organism studied. The most probable explanation for this finding is that, in human mononuclear phagocytes, disparate effector mecha- nisms are responsible for the control of different microorganisms. Accordingly, an effect on a single antimicrobial system by a deactivating mediator cannot explain the observed changes in the antimicrobial activities. No NO-producing activity that could explain antilisterial or anticonidial activity was detected. The capacity to produce reactive oxygen intermediates (ROI) did not explain all the observed effects, particularly in view of our previous finding that neither killing of conidia nor intracellular control of L. monocytogenes by nonactivated human macrophages depends on ROI generation [4, 5] . On the other hand, conidia from A. fumigatus are resistant to oxidative killing [1, 4] ; yet IL-IO that halved H-O, secretion evidently reduced anticonidial activity by affecting nonoxidative antimicrobial systems as well.
Suppression of TNF-a secretion has been proposed to explain the failure of deactivated macrophages to control intracellular parasites [10] . However, in the present fungal studies, exogenous TNF-a could not restore anticonidial activity.
Therefore, taken together, effects of deactivating mediators on previously undescribed effector functions of human macrophages must be assumed to explain deactivation of anticonidial activity.
In this context, the recent proposition that aspergillosis might be promoted by glucocorticoids through a direct effect on fungal growth is noteworthy [11] . We have previously appropriately controlled for such effects in our experiments that assessed germination rates in macrophages exposed to glucocorticoids [1, 4] . By demonstrating that glucocorticoids affect killing and digestion of conidia as well as germination rates, we further substantiate that the glucocorticoid target is the macrophage rather than the fungal spore in this setting. Such a mechanism is therefore also eliminated as explanation for the success of conidia in resisting glucocorticoid-treated macrophages.
In conclusion, the balancing effects of activating and deactivating signals appear to depend not only on the complexity of a network of simultaneous or sequential activating and deactivating mediators [10, 12] but also on the specific microbial pathogen and the antimicrobial mechanism operative in their control.
Bronchoalveolar lavage fluid cells from a cohort of 34 human immunodeficiency virus-infected persons with established Pneumocystis carinii pneumonia were examined for expression of tumor necrosis factor-a (TNF-a) mRNA by fluorescence in situ hybridization with an antisense riboprobe. Video image analysis was used to develop a quantitative assay that evaluates relative single-cell levels of mRNA. The resulting data were analyzed as an antisense-to-sense ratio and examined for correlation between TNF-a mRNA expression and other measures of disease severity. Higher levels of TNF-a mRNA were seen in persons who had higher levels of arterial oxygen.
Pulmonary manifestations are important in determining morbidity and mortality resulting from human immunodeficiency virus (HIV) infection. Increased susceptibility to opportunistic pulmonary infection was recognized when the clinical syndrome associated with HIV was first defined, and many causative organisms have been identified. Perhaps the best-known example is Pneumocystis carinii. However, as with other HIVassociated disease, the pathophysiologic mechanism that leads to pulmonary manifestations and the relationship between findings and outcome (e.g., lung function, patient survival) remain poorly understood.
Bronchoalveolar lavage (BAL) specimens have provided much information for diagnosis and research investigation of these conditions. Such studies indicate that identifiable opportunistic disease may be only one form of lung immunopathol- ogy in such patients. For example, 25%-50% of all HIVinfected persons show some evidence of alveolitis [1] , and a mixed NK and other T cell (chiefly CD8 cells) infiltration has been noted, not only early but also late in the course of HIV disease, when responder cells are depleted [2] . In the lung, the conventional selective target cell for HIV infection, the CD4 T cell, has not been found in appreciable numbers, probably reflecting the progressive dysfunction and eventual depletion of these cells.
The alternative CD4 target cells, mononuclear phagocytes (MP), are present in the lung in the form of alveolar macrophages (AM), and absolute numbers of these cells may be increased in both early stages of infection and late stages of disease [3] . This may be due to relative resistance to cytopathic effects of HIV; therefore, MP may serve not only as a potential reservoir for HIV but also as a primary vector for viral propagation [4] . Both viral propagation in MP and the effector-immunoregulatory function of MP are mediated by cytokines, and studies of cytokine production, either by protein detection or polymerase chain reaction (PCR) [5] , have shown that in HIVinfected persons there may be dysregulation of several cytokines, including tumor necrosis factor-a (TNF-a) .
TNF-a plays a pivotal role as a mediator in many physiologic and immunologic processes. In the lung, the AM is the first host cell to interact with infectious agents and to synthesize cytokines (such as TNF-rr) that may modulate the ensuing inflammatory response, thus serving both as a potential reservoir and as a "latent" source of cytokines. TNF-a released by AM may have
